$AGIO Agios Presents Positive Results from Phase 2 Study of Mitapivat in Non-transfusion-dependent α- and β-Thalassemia at the European Hematology Association Virtual Congress

on June 11, 2021 News and Tags: , , , with 0 comments
Time:
3:00 AM
Symbol:
AGIO
Source:
GlobeNewswire News Releases
Read more

$AGIO Agios Announces Updated Data from ACTIVATE and ACTIVATE-T Phase 3 Studies of Mitapivat in Pyruvate Kinase (PK) Deficiency at the European Hematology Association Virtual Congress

on June 11, 2021 News and Tags: , , , with 0 comments
Time:
3:00 AM
Symbol:
AGIO
Source:
GlobeNewswire News Releases
Read more

$AGIO Agios to Present Updated Data from Clinical Trials of Mitapivat in Pyruvate Kinase Deficiency and Thalassemia in Oral Presentations at the European Hematology Association Annual Congress

on May 12, 2021 News and Tags: , , , with 0 comments
Time:
10:00 AM
Symbol:
AGIO
Source:
GlobeNewswire News Releases
Read more

$AGIO Agios Reports Business Highlights and First Quarter 2021 Financial Results

on April 29, 2021 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
AGIO
Source:
GlobeNewswire News Releases
Read more

$AGIO Agios Shareholders Approve Sale of Oncology Business to Servier

on March 25, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
AGIO
Source:
GlobeNewswire News Releases
Read more